Fact Sheets 2018

Total Page:16

File Type:pdf, Size:1020Kb

Fact Sheets 2018 Japan Tobacco Inc. Fact Sheets 2018 001 Financial Data 009 International Tobacco Business 012 Japanese Domestic Tobacco Business 023 Number of Employees/Subsidiaries and Affiliates 024 Glossary Fact Sheets Financial Data In 2015, the beverage business was classified as discontinued operations in accordance with IFRS requirements. Consequently, profit (loss) and some items from continuing operations and discontinued operations are presented separately for the financial results of 2015. To provide a fair business performance comparison with the results of 2016, we provide the figures with a focus on continuing operations of 2015, except those related to the balance sheet, which are on a continuing and discontinued operations combined basis. In addition, FY2014 was a transitional period due to the unification of the accounting period. For the purpose of fair business performance comparison, we are providing figures for the twelve-month (January 1 – December 31, 2014) period with regard to all business segments in continuing operations (Like-for-Like basis). Net Sales Excluding Excise Taxes/Revenue Billions of yen IFRS Continuing operations Like-for-Like 3,000 2,000 1,000 0 FY2011 FY2011 FY2012 FY2013 2014 2015 2016 2017 2018 Total 2,547.1 2,033.8 2,120.2 2,399.8 2,259.2 2,252.9 2,143.3 2,139.7 2,216.0 International Tobacco Business 966.3 966.3 1,010.7 1,270.0 1,328.0 1,317.2 1,199.2 1,237.6 1,312.3 Japanese Domestic Tobacco Business 1,147.5 646.2 687.1 710.3 687.4 677.3 684.2 626.8 621.4 Pharmaceutical Business 50.6 47.4 53.2 64.4 65.8 75.6 87.2 104.7 114.0 Food Business 367.0 Beverage Business 188.8 185.5 184.5 — — — — — P rocessed Food Business 170.7 168.7 156.9 161.2 165.8 164.1 163.1 161.4 Other Business 15.7 14.6 15.0 13.6 16.9 17.0 8.6 7.5 6.8 Adjusted Net Sales Excluding Excise Taxes/ Core Revenue I nternational Tobacco Business 894.6 894.6 943.1 1,200.7 1,258.2 1,252.5 1,138.8 1,177.0 1,250.7 Japanese Domestic Tobacco Business 596.8 611.9 654.0 676.2 649.8 642.2 649.7 590.6 582.4 SG&A Expenses (IFRS) Billions of yen IFRS Continuing operations Like-for-Like 1,000 750 500 250 0 FY2011 FY2012 FY2013 2014 2015 2016 2017 2018 SG&A 733.2 733.5 828.9 839.6 789.3 754.1 786.9 770.4 Advertising expenses 21.5 20.6 21.7 23.1 25.6 26.1 24.4 29.1 Promotion expenses 128.0 137.5 147.8 117.7 120.3 124.8 112.2 106.2 Shipping, warehousing expenses 27.9 27.1 27.1 24.7 26.9 26.8 26.9 1.2 Commission 41.0 41.2 49.3 50.0 51.3 50.9 54.5 52.7 Employee benefit expenses 235.1 241.5 275.8 321.8 264.7 241.8 254.0 269.0 Research and development expenses 51.5 56.9 57.1 56.0 57.8 58.2 60.6 65.4 Depreciation and amortization 58.5 59.1 68.8 60.9 66.0 79.1 81.3 87.9 I mpairment losses on other than financial assets 7.0 3.2 2.4 22.3 9.5 1.2 3.4 8.5 Regulatory fine in Canada ——————— — L osses on sale and disposal of property, plant and equipment, intangible assets, and investment property 11.5 9.3 9.5 16.7 19.2 11.3 4.8 8.8 C ooperation fee for terminating leaf tobacco farming 12.5 — — — — — — — Impairment losses of investments in associates — — 9.7 — — — — — Other 138.7 137.2 159.7 146.3 148.1 134.1 164.7 141.6 Japan Tobacco Inc. 001 Fact sheets 2018 R&D Expenses Billions of yen IFRS Continuing operations Like-for-Like 80 60 40 20 0 FY2011 FY2011 FY2012 FY2013 2014 2015 2016 2017 2018 R&D 53.6 51.5 56.9 57.1 56.0 57.8 58.2 60.6 65.4 International Tobacco Business 5.2 5.2 5.8 6.9 7.9 8.3 8.3 8.0 8.5 Japanese Domestic Tobacco Business 20.2 20.0 19.0 18.4 18.0 17.4 17.8 18.5 18.1 Pharmaceutical Business 26.7 24.9 30.7 30.5 28.9 30.7 30.7 32.6 37.1 Food Business 0.6 Beverage Business ——————— — Processed Food Business 0.6 0.6 0.6 0.5 0.5 0.6 0.7 0.8 Note: The aforementioned research and development expenses included 0.8 billion yen for 2017 and 2018, respectively (IFRS), relating to basic research not affiliated to any segment (plant biotechnology related research, etc.) and conducted by JT corporate division. EBITDA/Adjusted EBITDA IFRS Billions of yen 800 600 400 200 0 FY2011 FY2011 FY2012 FY2013 EBITDA/Adjusted EBITDA 581.1 577.1 622.0 751.7 International Tobacco Business 312.6 314.8 343.2 451.6 Japanese Domestic Tobacco Business 272.5 262.3 281.3 302.1 Pharmaceutical Business (12.3) (10.0) (12.7) (5.4) Food Business 21.5 Beverage Business 14.6 12.4 8.7 Processed Food Business 5.4 7.4 7.5 Other Business (13.3) (9.8) (9.6) (12.7) Adjusted Operating Profit (IFRS) Billions of yen Continuing operations Like-for-Like 800 600 400 200 0 2014 2015 2016 2017 2018 Adjusted Operating Profit 661.0 626.7 586.8 585.3 595.5 International Tobacco Business 447.1 394.4 336.2 351.3 384.5 Japanese Domestic Tobacco Business 238.7 254.1 260.2 232.3 209.0 Pharmaceutical Business (7.3) (2.3) 9.7 24.1 28.4 Processed Food Business 1.4 2.7 5.0 5.4 4.1 Other Business/Elimination (18.9) (22.2) (24.4) (27.8) (30.6) Note: Figures for adjusted operating profit of 2014 are unaudited. Japan Tobacco Inc. 002 Fact sheets 2018 Operating Income/Operating Profit Billions of yen IFRS Continuing operations Like-for-Like 800 600 400 200 0 FY2011 FY2011 FY2012 FY2013 2014 2015 2016 2017 2018 Operating Income/Operating Profit 374.7 459.2 532.2 648.3 572.6 565.2 593.3 561.1 565.0 International Tobacco Business 185.3 252.4 289.4 376.4 379.5 346.9 301.8 325.6 339.5 Japanese Domestic Tobacco Business 229.6 209.3 241.3 258.1 181.5 249.2 244.1 215.8 192.5 Pharmaceutical Business (16.1) (13.5) (16.2) (9.0) (7.3) (2.3) 9.7 24.1 26.3 Food Business (6.3) Beverage Business 4.5 2.3 (2.1) ———— — Processed Food Business (2.5) (5.8) (0.2) (1.2) 3.2 5.0 5.4 2.9 Other Business (17.9) 9.0 21.2 25.0 20.2 (31.8) 32.7 (9.8) 3.8 Financial Income and Expenses (IFRS) Billions of yen IFRS Continuing operations Like-for-Like 40 30 20 10 0 FY2011 FY2012 FY2013 2014 2015 2016 2017 2018 Financial Income 5.6 5.5 8.4 14.7 15.0 6.6 4.8 5.8 Financial Expenses (23.4) (28.4) (20.4) (12.8) (15.1) (21.7) (27.3) (39.3) Net Income/Profit (attributable to owners of the parent company) Billions of yen IFRS Continuing operations Like-for-Like 500 400 300 200 100 0 FY2011 FY2011 FY2012 FY2013 2014 2015 2016 2017 2018 Net Income/Profit (attributable to owners of the parent company) 227.4 320.9 343.6 428.0 391.4 398.5 421.7 392.4 385.7 Japan Tobacco Inc. 003 Fact sheets 2018 FY2014, a transitional period for the change in accounting period, covers nine months from April 1, 2014 to December 31, 2014 for the Japanese domestic business. The same change in accounting period is applied to the Company’s consolidated subsidiaries whose current closing date was other than December 31 (Reported basis). For the purpose of a fair comparison and reference, we are providing figures for the twelve-month (January 1–December 31) period with regard to all business segments in continuing operations (Like-for-Like basis). Earnings per Share (EPS)/Basic Earning per Share Yen IFRS Yen 90,000 270.54 300 235.48 235.47 219.10 215.31 199.67 181.07 60,000 168.50 200 30,000 100 0 0 FY2011 FY2011 FY2012 FY2013 FY2014 2015 2016 2017 2018 EPS/Basic Earning per Share 23,883 168.50 181.07 235.48 199.67 270.54 235.47 219.10 215.31 Diluted EPS 23,873 168.44 180.98 235.35 199.56 270.37 235.33 218.97 215.20 Notes: A 200 for 1 stock split went into effect on July 1, 2012. Calculated on the assumption that this share split was conducted at the beginning of FY2011 (April 1, 2011). The IFRS figures refer to the right hand scale in the graph. Return on Equity (ROE)/ROE (attributable to owners of the parent company) % IFRS 25.0 20.0 15.0 10.0 5.0 0 FY2011 FY2011 FY2012 FY2013 FY2014 2015 2016 2017 2018 ROE/ROE (attributable to owners of the parent company) 15.0 20.3 20.0 19.9 14.4 19.5 17.2 15.0 14.3 Return on Assets (ROA) % IFRS 20 15 10 5 0 FY2011 FY2011 FY2012 FY2013 FY2014 2015 2016 2017 2018 ROA 10.3 12.1 13.5 15.0 10.8 14.8 12.4 10.8 10.0 Operating Income Margin/Operating Profit Margin % IFRS 30 20 10 0 FY2011 FY2011 FY2012 FY2013 FY2014 2015 2016 2017 2018 Operating Income Margin/ Operating Profit Margin 14.7 22.6 25.1 27.0 23.2 29.2 27.7 26.2 25.5 Japan Tobacco Inc.
Recommended publications
  • News Analysis
    Tob Control: first published as 10.1136/tc.2009.034454 on 2 December 2009. Downloaded from KAZAKHSTAN: PUBLIC SMOKING BAN News analysis Like Bulgaria (see page 429), just a few years ago Kazakhstan would not have been NEW ZEALAND: INDUSTRY FACES GRILLING URUGUAY: NEW HEALTH WARNINGS expected to turn up on a list of countries OVER MAORIS Uruguay is set to have the largest health likely to ban smoking in all public places. In which country might one hear the warnings in the world. A new set of six But as the health ministry said when most refreshingly straight talk about the graphic pack warnings, each covering 80 announcing such a move in September, tobacco industry in the national legisla- per cent of the front and back of the pack, the central Asian country is now following the recommendations of the World Health ture? There may be no easy, single was finalised in September. They will Organization, according to whose data answer, but recent experience suggests have to be in place by 1 March 2010, more than 30,000 people die every year in that New Zealand must be a contender. though the warnings they replace, which Kazakhstan from smoking. Sports stadiums While the majority of New Zealanders covered 50 per cent of the pack, were and public transport facilities were already have been reducing their tobacco con- ordered to be expanded to 80 per cent by smoke-free, but Kazakh bars and night- sumption for several decades, the indigen- December. The two large sides of the pack clubs, and all other remaining public areas ous Maori people still have alarmingly are not the only place where Uruguayan not previously covered by the ban, have high smoking rates.
    [Show full text]
  • Illicit Tobacco Trade in Georgia: Prevalence and Perceptions Megan Little,1 Hana Ross,1 George Bakhturidze ‍ ,2,3 Iago Kachkachishvili4
    Original research Tob Control: first published as 10.1136/tobaccocontrol-2018-054839 on 18 January 2019. Downloaded from Illicit tobacco trade in Georgia: prevalence and perceptions Megan Little,1 Hana Ross,1 George Bakhturidze ,2,3 Iago Kachkachishvili4 ► Additional material is ABSTRact The new government coming to power in 2004 published online only. To view Background In lower- income and middle- income decided to double and triple taxes for imported please visit the journal online filtered and domestic filtered cigarettes, respec- (http:// dx. doi. org/ 10. 1136/ countries, limited research exists on illicit tobacco tobaccocontrol- 2018- 054839). trade and its responsiveness to taxation. Tobacco taxes tively. In preparation for this increase, tobacco are critical in reducing tobacco consumption, thereby companies prepurchased tax stamps (introduced in 1 Economics, Southern Africa improving public health. However, the tobacco industry 1999) with the lower 2004 value, to use in their Labour and Development 2005 sales. This resulted in an artificial tax revenue Research Unit, University of claims that tax increases will increase illicit tobacco Cape Town, Cape Town, South trade. Therefore, research evidence on the size of the increase in 2004 followed by a sharp fall in early Africa illicit cigarette market is needed in Georgia and other 2005, when the new tax came into effect. Tobacco 2 Tobacco Control Research, low- income and middle- income countries to inform companies then asserted that the tax revenue fall FCTC Implementation and tobacco tax policies. was driven by a sharp increase in illicit trade from Monitoring Center in Georgia, 10% in 2003 to 65% in post-2005.3 This persuaded Tbilisi, Georgia Methods In 2017, a household survey using stratified 3Health Promotion Research, multistage sampling was conducted in Georgia with the government to lower taxes by 30%–40% in Georgian Health Promotion and 2997 smokers, to assess illicit tobacco consumption.
    [Show full text]
  • Assonance a Journal of Russian & Comparative Literary Studies
    ISSN 2394-7853 Assonance A Journal of Russian & Comparative Literary Studies No.21 January 2021 Department of Russian & Comparative Literature University of Calicut Kerala – 673635 Assonance: A Journal of Russian & Comparative Literary Studies No.21, January 2021 ISSN 2394-7853 Listed in UGC Care ©2021 Department of Russian & Comparative Literature, University of Calicut Editors: Dr. K.K. Abdul Majeed (Assistant Professor & Head) Dr. Nagendra Shreeniwas (Associate Professor, CRS, SLL&CS, JNU, New Delhi) Sub Editor: Sameer Babu Kavad Board of Referees: 1. Prof. Amar Basu, (Retd.), JNU, New Delhi 2. Prof. Govindan Nair (Retd.), University of Kerala 3. Prof. Ranjana Banerjee, JNU, New Delhi 4. Prof. Kandrapa Das, Guahati University, Assam 5. Prof. Sushant Kumar Mishra, JNU, New Delhi 6. Prof. T.K. Gajanan, University of Mysore 7. Prof. Balakrishnan K, Amrita School of Arts and Sciences, Kochi 8. Dr. S.S. Rajput, EFLU, Hyderabad 9. Smt. Sreekumari S, (Retd.), University of Calicut, Kerala 10. Dr. V.K. Subramanian, University of Calicut, 11. Dr. Arunim Bandyopadhyay, JNU, New Delhi 12. Dr. K.M. Sherrif, University of Calicut, Kerala 13. Dr. K.M. Anil, Malayalam University, Kerala 14. Dr. Sanjay Kumar, EFLU, Hyderabad 15. Dr. Krishnakumar R.S, University of Kerala Frequency: Annual Published by: Department of Russian & Comparative Literature, University of Calicut, Thenhipalam, Malappuram, Kerala – 673635 Articles in the journal reflect the views of the respective authors only and do not reflect the view of the editors, the journal, the department and/or the university. ii Notes for contributors Assonance is an ISSN, UGC-CARE listed, multilingual, refereed, blind peer reviewed, annual publication of the Department of Russian & Comparative Literature, University of Calicut.
    [Show full text]
  • Cigarettes and Tobacco Products Removed from the California Tobacco Directory by Brand
    Cigarettes and Tobacco Products Removed From The California Tobacco Directory by Brand Brand Manufacturer Date Comments Removed #117 - RYO National Tobacco Company 10/21/2011 5/6/05 Man. Change from RBJ to National Tobacco Company 10/20's (ten-twenty's) M/s Dhanraj International 2/6/2012 2/2/05 Man. Name change from Dhanraj Imports, Inc. 10/20's (ten-twenty's) - RYO M/s Dhanraj International 2/6/2012 1st Choice R.J. Reynolds Tobacco Company 5/3/2010 Removed 5/2/08; Reinstated 7/11/08 32 Degrees General Tobacco 2/28/2010 4 Aces - RYO Top Tobacco, LP 11/12/2010 A Touch of Clove Sherman 1400 Broadway N.Y.C. Inc. 9/25/2009 AB Rimboche' - RYO Daughters & Ryan, Inc. 6/18/2010 Ace King Maker Marketing 5/21/2020 All American Value Philip Morris, USA 5/5/2006 All Star Liberty Brands, LLC 5/5/2006 Alpine Philip Morris, USA 8/14/2013 Removed 5/4/07; Reinstated 5/8/09 Always Save Liberty Brands, LLC 5/4/2007 American R.J. Reynolds Tobacco Company 5/6/2005 American Bison Wind River Tobacco Company, LLC 9/22/2015 American Blend Mac Baren Tobacco Company 5/4/2007 American Harvest Sandia Tobacco Manufacturers, Inc. 8/31/2016 American Harvest - RYO Truth & Liberty Manufacturing 8/2/2016 American Liberty Les Tabacs Spokan 5/12/2006 Amphora - RYO Top Tobacco, LP 11/18/2011 Andron's Passion VCT 5/4/2007 Andron's Passion VCT 5/4/2007 Arango Sportsman - RYO Daughters & Ryan, Inc. 6/18/2010 Arbo - RYO VCT 5/4/2007 Ashford Von Eicken Group 5/8/2009 Ashford - RYO Von Eicken Group 12/23/2011 Athey (Old Timer's) Daughters & Ryan, Inc.
    [Show full text]
  • (With) Shakespeare (/783437/Show) (Pdf) Elizabeth (/783437/Pdf) Klett
    11/19/2019 Borrowers and Lenders: The Journal of Shakespeare and Appropriation ISSN 1554-6985 V O L U M E X · N U M B E R 2 (/current) S P R I N G 2 0 1 7 (/previous) S h a k e s p e a r e a n d D a n c e E D I T E D B Y (/about) E l i z a b e t h K l e t t (/archive) C O N T E N T S Introduction: Dancing (With) Shakespeare (/783437/show) (pdf) Elizabeth (/783437/pdf) Klett "We'll measure them a measure, and be gone": Renaissance Dance Emily Practices and Shakespeare’s Romeo and Juliet (/783478/show) (pdf) Winerock (/783478/pdf) Creation Myths: Inspiration, Collaboration, and the Genesis of Amy Romeo and Juliet (/783458/show) (pdf) (/783458/pdf) Rodgers "A hall, a hall! Give room, and foot it, girls": Realizing the Dance Linda Scene in Romeo and Juliet on Film (/783440/show) (pdf) McJannet (/783440/pdf) Prokofiev’s Romeo and Juliet: Some Consequences of the “Happy Nona Ending” (/783442/show) (pdf) (/783442/pdf) Monahin Scotch Jig or Rope Dance? Choreographic Dramaturgy and Much Emma Ado About Nothing (/783439/show) (pdf) (/783439/pdf) Atwood A "Merry War": Synetic's Much Ado About Nothing and American Sheila T. Post-war Iconography (/783480/show) (pdf) (/783480/pdf) Cavanagh "Light your Cigarette with my Heart's Fire, My Love": Raunchy Madhavi Dances and a Golden-hearted Prostitute in Bhardwaj's Omkara Biswas (2006) (/783482/show) (pdf) (/783482/pdf) www.borrowers.uga.edu/7165/toc 1/2 11/19/2019 Borrowers and Lenders: The Journal of Shakespeare and Appropriation The Concord of This Discord: Adapting the Late Romances for Elizabeth the
    [Show full text]
  • Participating Manufacturers
    PARTICIPATING MANUFACTURERS under the Master Settlement Agreement as of June 12, 2015 The following list of brand name tobacco products sold in the United States by Participating Manufacturers has been prepared based on information provided to NAAG by the Participating Manufacturers. NAAG does not assume responsibility for the accuracy or completeness of this information. This list should not and cannot be used to determine whether particular tobacco products are legal for sale in any particular State. Retailers should consult their respective State laws and directories in determining which brands, brand families, or brand styles are legal for sale. Anderson Tobacco Company, LLC SPM from 11/05/2003 – 2/15/2007 Deleted as SPM- no longer in existence Bekenton, S.A. SPM since 6/25/2003 Designated Representatives: Dennis Edward Bruce Esq. Bekenton S.A. 690 Lincoln Road, Suite 303 Miami Beach, Florida 33139 Phone: (888) 672-4991 Fax: (800) 887-1723 Brands: Canary Islands Cigar Co. SPM since 9/26/2003* Designated Representatives: Roberto F. Fleitas, Esquire Federico González de Aledo y Buergo 782 N.W. Lejeune Road Fabrica Record Suite 530 Barrio Chamberi S/N Miami, Florida 33126 Santa Cruz de Tenerife, Canary Islands, Spain Telephone: (305) 442-1439 Telephone: 011-34-922-10-13-66 Facsimile: (305) 442-9944 Facsimile: 011-34-922-20-03-61 E-Mail: [email protected] E-Mail: [email protected] * On September 26, 2003 the Settling States entered into a Forbearance Agreement with Tabacos de Canarias S.L. (“CITA”) and its wholly-owned subsidiary Canary Island Cigar Co. (“CIC”), and approved Amendment 22 to the Master Settlement Agreement, as a result of which CIC assumed all unsatisfied MSA payment obligations for CITA-made cigarettes sold in the United States from 1999 - 2002 and became a Participating Manufacturer for all CITA-made cigarettes sold in the United States from 2003 forward.
    [Show full text]
  • Nicotine, Tar, and Mutagenicity Of
    Journal of Health Science, 55(3) 421–427 (2009) 421 Nicotine, Tar, and Mutagenicity of Mainstream Smoke Generated by Machine Smoking with International Organization for Standardization and Health Canada Intense Regimens of Major Japanese Cigarette Brands Osamu Endo,∗,a Mariko Matsumoto,b Yohei Inaba,b Kazutoshi Sugita,c Daisuke Nakajima,d Sumio Goto,a Hiromitsu Ogata,b and Gen Suzukib aSchool of Life and Environmental Science, Azabu University, 1–17–71 Fuchinobe, Sagamihara, Kanagawa 229–8501, Japan, bDepartment of Environmental Health National Institute of Public Health, 2–3–6 Minami, Wako, Saitama 351–0197, Japan, cAnalysis Division Mitsubishi Chemical Analytech Co., Ltd., 8–5–1 Chuo, Ami-cho, Inashiki-gun, Ibaraki 300–0332, Japan and dResearch Center for Enviromental Risk National Institute for Environmental Studies, 16–2 Onogawa, Tsukuba, Ibaraki 305–0053, Japan (Received February 4, 2009; Accepted March 12, 2009; Published online March 31, 2009) Based upon the Framework Convention on Tobacco Control (FCTC), the World Health Organization (WHO) hasrecommended that health authorities disclose toxicological properties of cigarette mainstream smoke (MSS) obtained not only according to US Federal Trade Commission (FTC)/International Organization for Standardization (ISO) conditions but also by more intense conditions such as the Health Canada Intense (HCI) condition. This is because smokers are believed to smoke more intensely than machine smoking under the ISO regimen. Because there are no previous reports on the toxicological properties of MSS of Japanese cigarettes under the HCI condition, we determined nicotine and water contents by gas chromatography (GC-MS and GC/Thermal Conductivity Detector (TCD)) for three product lots each of the ten bestselling brands of Japanese cigarettes following the WHO protocol.
    [Show full text]
  • JT Applies to Amend Retail Prices of Tobacco Products in Japan in Response to a Planned Excise Tax Increase
    FOR IMMEDIATE RELEASE Tokyo, July 30, 2021 JT Applies to Amend Retail Prices of Tobacco Products in Japan in Response to a Planned Excise Tax Increase Japan Tobacco Inc. (JT) (TSE:2914) today announces that it has applied to the Ministry of Finance for approval* to amend the retail prices of its tobacco products in Japan in conjunction with the planned excise tax increase on October 1, 2021. The Company has applied for the retail price amendment for a total of 173 products, including 127 cigarette products, 18 cigarillo products, three pipe tobacco products, three cut tobacco products, 22 snuff tobacco products. The Japanese domestic tobacco market continues to experience decreasing sales volumes due to structural factors including the aging and declining adult population together with increasingly stringent smoking restrictions. As a result, the costs for maintaining the product quality and services are rising. Under these circumstances, while JT has been implementing cost optimization measures in line with a projected further decline of sales volume, it has become even more challenging to maintain the same quality and services that meet our consumer’s satisfaction. In this context, JT has applied to amend the retail prices of cigarettes, which exceeds the excise tax hike of cigarettes (1.0 yen per stick), revised tax structure for light weight cigarillos, while taking into account further increases in costs. JT has decided to amend the retail prices of its tobacco products, however such increase varies among different brands and products, to ensure that the quality of each product will be maintained and that consumer expectations continue to be met.
    [Show full text]
  • 2019 Second Quarter Results
    Tokyo, July 31, 2019 2019 Second Quarter Results Highlights First half adjusted operating profit at constant FX increased 5.9% year-on-year, mainly driven by pricing gains in both the international and Japanese domestic tobacco businesses. On a reported basis, adjusted operating profit decreased 9.4% due to unfavorable currency movements. Operating profit and profit attributable to owners of the parent increased driven by a one-time compensation gain in the pharmaceutical business. FY2019 forecast for consolidated adjusted operating profit at constant FX remains unchanged. The Company announced the interim dividend of JPY 77 per share as stated in the “Business Plan 2019.” Key business segment information (January – June): International tobacco business • Adjusted operating profit at constant FX on a USD basis grew 9.3% mainly driven by solid pricing gains. On a JPY basis, adjusted operating profit decreased 13.5% due to unfavorable currency movements. • Total shipment volume grew 8.2% driven by acquisitions. Excluding these, volume was up 0.1% driven by solid GFB performance and continued market share gains, notably in Taiwan and the UK. • Expansion of Logic Compact continued with the addition of 12 new markets in the period. • Full year currency-neutral adjusted operating profit is expected to grow 10.2% year-on-year. Japanese domestic tobacco business • Adjusted operating profit increased 5.5% driven by cigarette pricing gains. • Ploom TECH+ sales expanded nationwide in June contributing to RRP sales volume growth. JT market share in the category is estimated at approximately 8%. • Ploom S will be rolled out nationwide in August 2019. • Full year adjusted operating profit is expected to decline 4.3% year-on-year.
    [Show full text]
  • Investment Leading to Sustainable Growth
    Corporate Information 048 Corporate Governance 058 History of the JT Group Japan Tobacco Inc. Annual Report FY2017 062 Regulation and Other Relevant Laws Year ended December 31, 2017 065 Litigation 066 Members of the Board, Audit Investment Operations & Analysis and Supervisory Board Members, leading and Executive Officers to sustainable 018 Industry Overview 067 Members of the JTI growth. 018 Tobacco Business Executive Committee 021 Pharmaceutical Business 067 Corporate Data 021 Processed Food Business 068 Investor Relations Activity 022 Review of Operations 069 Shareholder Information 022 International Tobacco Business 028 Japanese Domestic Tobacco Business 032 Global Tobacco Strategy 034 Pharmaceutical Business 038 Processed Food Business 040 Risk Factors Management 044 JT Group and Sustainability 046 Environmental, Social and 001 Performance Indicators Governance Initiatives 002 At a Glance 004 Consolidated Five-Year Financial Summary 006 Message from the Chairman and CEO Financial Information 008 CEO Business Review 010 Highlights (JT Group’s 2017) 071 Message from CFO 012 Management Principle, Strategic 072 Financial Review Framework and Resource Allocation 080 Consolidated Financial Statements 014 Business Plan 2018 086 Notes to Consolidated 015 Role and Target of Each Business Financial Statements 016 Performance Measures 139 Independent Auditor’s report 140 Glossary of Terms Management Performance Indicators Adjusted Operating Profit Dividend per Share 585.3 14 0 (JPY BN) (JPY) - 0.3% +7. 7 % Year-on-Year Change Year-on-Year Change - 0.6% Factsheets available at: Year-on-Year Change at Constant Exchange Rates https://www.jt.com/investors/results/annual_report/ Unless the context indicates otherwise, references in this Annual Report to ‘we’, ‘us’, In addition, these forward-looking statements are necessarily dependent upon ‘our’, ‘Japan Tobacco’, ‘JT Group’ or ‘JT’ are to Japan Tobacco Inc.
    [Show full text]
  • Analysis of a Tobacco Vector and Its Actions in China: the Activities of Japan Tobacco Peisen He1,2, Takeaki Takeuchi1*, Eiji Yano1
    He et al. Tobacco Induced Diseases 2010, 8:13 http://www.tobaccoinduceddiseases.com/content/8/1/13 REVIEW Open Access Analysis of a tobacco vector and its actions in China: the activities of Japan tobacco Peisen He1,2, Takeaki Takeuchi1*, Eiji Yano1 Abstract Japan Tobacco (JT) is the third largest tobacco company in the world, and China, the world’s largest tobacco consumer, is one of the most important targets for JT. To provide information for tobacco control, we reviewed and analyzed JT and its tactics and strategies in the Chinese market mainly by systematic examination of documents which are made available in the University of California, San Francisco Legacy Tobacco Documents Library. As a result, JT has had a special interest to expand sales of its cigarettes in the Chinese market. Introduction 25.7% of Japanese adults smoke [4]. Besides, the 1987 Smoking is a particular challenge for public health suspension of import tariffs on cigarettes led to rapidly because unlike many other pathogens, this leading cause increased competition in JT’s domestic tobacco market, of morbidity and mortality worldwide continues to be which decreased JT’s sales and market share. To combat actively promoted by large multinational corporations the increased competitive pressures, JT has become and governments. Previous writers have described the more sophisticated and focused in their marketing activities of the two largest transnational tobacco cor- efforts, transforming the company from a Japanese porations (TTC) as summarized later. In this paper we cigarette “manufacturer/distributor” to an International report on the activities of Japan Tobacco (JT), the third cigarette “manufacturer/marketer”[5,6].
    [Show full text]
  • JTI Response to the UK Department of Health's Consultation on the Future
    Response to the UK Department of Health’s Consultation on the Future of Tobacco Control 5 September 2008 Japan Tobacco International is a subsidiary of Japan Tobacco Inc., the world’s third largest global tobacco company. It produces three of the top five worldwide cigarette brands: Winston, Mild Seven and Camel. Other international brands include Benson & Hedges, Silk Cut, Sobranie of London, Glamour and LD. With headquarters in Geneva, Switzerland, and net sales of USD 8 billion in the fiscal year ended December 31, 2007, Japan Tobacco International has more than 22,000 employees and operations in 120 countries. Since April 2007, Gallaher Limited (“Gallaher”), the UK-based tobacco products manufacturer, has also formed part of the Japan Tobacco Group. In this response to the FTC Document, we use the term “JTI” to refer collectively to Japan Tobacco International and Gallaher. JTI, which has its UK headquarters in Weybridge, Surrey, has a long-standing, significant presence in the UK market. Its UK cigarette brand portfolio includes Benson & Hedges, Silk Cut, Camel, Mayfair, Sovereign and More, as well as a number of other tobacco products including cigars (such as Hamlet), roll-your-own tobacco and pipe tobacco. JTI manufactures product for the UK market at sites in the UK (in Northern Ireland and Cardiff) and outside it (for example, in Germany). EXECUTIVE SUMMARY JTI agrees with the key policy rationale underlying the Department of Health’s Consultation on the Future of Tobacco Control (the FTC Document): “children and young people” should not smoke, and should not be able to buy tobacco products.
    [Show full text]